132 related articles for article (PubMed ID: 10632384)
1. Incidence of severe streptococcal-related diseases in Italian children in an era of high group A streptococcal resistance to macrolides. Italian Group A Streptococcal Resistance to Macrolides Study Group.
Principi N; Marchisio P
J Chemother; 1999 Oct; 11(5):379-84. PubMed ID: 10632384
[TBL] [Abstract][Full Text] [Related]
2. Nationwide survey in Italy of treatment of Streptococcus pyogenes pharyngitis in children: influence of macrolide resistance on clinical and microbiological outcomes. Artemis-Italy Study Group.
Varaldo PE; Debbia EA; Nicoletti G; Pavesio D; Ripa S; Schito GC; Tempera G
Clin Infect Dis; 1999 Oct; 29(4):869-73. PubMed ID: 10589905
[TBL] [Abstract][Full Text] [Related]
3. [Update on antibiotic sensitive Streptococcus pyogenes in a pediatric population].
Gené A; González-Cuevas A; Muñoz C; Luaces C; Latorre C
Enferm Infecc Microbiol Clin; 2000 Mar; 18(3):144-5. PubMed ID: 10905020
[No Abstract] [Full Text] [Related]
4. [The genetic features of drug resistance to group A streptococcus and macrolides antibiotics among pediatric patients in Beijing 2012].
Peng XM; Yang P; Liu S; Li J; Zhang DT; Liu YM; Liang HJ; Cui SJ; Wu SS; Wang QY
Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Nov; 47(11):1040-4. PubMed ID: 24507235
[TBL] [Abstract][Full Text] [Related]
5. Rapid increase of resistance to erythromycin and clindamycin in Streptococcus pyogenes in Italy, 1993-1995. The Italian Surveillance Group for Antimicrobial Resistance.
Cornaglia G; Ligozzi M; Mazzariol A; Valentini M; Orefici G; Fontana R
Emerg Infect Dis; 1996; 2(4):339-42. PubMed ID: 9011381
[TBL] [Abstract][Full Text] [Related]
6. Macrolide prescriptions and erythromycin resistance of Streptococcus pyogenes.
Gagliotti C; Nobilio L; Milandri M; Moro ML;
Clin Infect Dis; 2006 Apr; 42(8):1153-6. PubMed ID: 16575736
[TBL] [Abstract][Full Text] [Related]
7. [Septicemia caused by A, B, C and G groups of beta-hemolytic streptococci].
Kechrid A; Aïssa N; Bouzouaïa N; Ben Hassen A; Fendri C; Ben Redjeb S
Presse Med; 1993 May; 22(19):896-8. PubMed ID: 8378278
[TBL] [Abstract][Full Text] [Related]
8. Macrolide resistance in group A beta haemolytic Streptococcus isolated from outpatient children in Latvia.
Zavadska D; Bērziņa D; Drukaļska L; Pugacova N; Miklasevics E; Gardovska D
APMIS; 2010 May; 118(5):366-70. PubMed ID: 20477812
[TBL] [Abstract][Full Text] [Related]
9. [Streptococcus pyogenes and resistance to macrolides: experience at Monza].
Minerva Pediatr; 1998; 50(1-2):XII-XIII. PubMed ID: 9658791
[No Abstract] [Full Text] [Related]
10. Macrolide resistance in streptococcal pharyngitis.
Lavergne V; Thibault L; Garceau R
CMAJ; 2007 Jul; 177(2):177. PubMed ID: 17638961
[No Abstract] [Full Text] [Related]
11. Inducible clindamycin resistance in β-hemolytic streptococci and Streptococcus pneumoniae.
Megged O; Assous M; Weinberg G; Schlesinger Y
Isr Med Assoc J; 2013 Jan; 15(1):27-30. PubMed ID: 23484235
[TBL] [Abstract][Full Text] [Related]
12. [Streptococcus pyogenes or group A streptococcal infections in child: French national reference center data].
Bidet P; Plainvert C; Doit C; Mariani-Kurkdjian P; Bonacorsi S; Lepoutre A; Bouvet A; Poyart C; Bingen E
Arch Pediatr; 2010 Feb; 17(2):201-8. PubMed ID: 19926269
[TBL] [Abstract][Full Text] [Related]
13. Erythromycin-resistant group A streptococci.
Linder JA; Stafford RS
N Engl J Med; 2002 Aug; 347(8):614-5; author reply 614-5. PubMed ID: 12192025
[No Abstract] [Full Text] [Related]
14. The trend of macrolide resistance and emm types of group A streptococci from children at a medical center in southern Taiwan.
Chuang PK; Wang SM; Lin HC; Cho YH; Ma YJ; Ho TS; Shen CF; Liu CC
J Microbiol Immunol Infect; 2015 Apr; 48(2):160-7. PubMed ID: 24094501
[TBL] [Abstract][Full Text] [Related]
15. Oral antimicrobial susceptibilities of Streptococcus pyogenes recently isolated in five countries.
Bandak SI; Turnak MR; Allen BS; Bolzon LD; Preston DA
Int J Clin Pract; 2000 Nov; 54(9):585-8. PubMed ID: 11220986
[TBL] [Abstract][Full Text] [Related]
16. Clinical and epidemiologic features of invasive group A streptococcal infections in children.
Mulla ZD
Pediatr Int; 2007 Jun; 49(3):355-8. PubMed ID: 17532835
[TBL] [Abstract][Full Text] [Related]
17. Macrolide resistance in group A Streptococcus.
Freeman AF; Shulman ST
Pediatr Infect Dis J; 2002 Dec; 21(12):1158-60. PubMed ID: 12488669
[No Abstract] [Full Text] [Related]
18. [Macrolides in the treatment of streptococcal pharyngitis: not all effective].
Alós JI
Med Clin (Barc); 1999 Jan; 112(1):18-9. PubMed ID: 10027181
[No Abstract] [Full Text] [Related]
19. Group A streptococcal bacteremia: outcome and prognostic factors.
Vallalta Morales M; Soriano Navarro CJ; Salavert Lletí M; Montero Alonso M; Pérez Bellés C; López Aldeguer J; Otero MC; Gobernado Serrano M
Rev Esp Quimioter; 2006 Dec; 19(4):367-75. PubMed ID: 17235407
[TBL] [Abstract][Full Text] [Related]
20. [Isolated susceptibility of Streptococcus pyogenes to 3 macrolides].
Sakran W; Raz R; Colodner R; Keness Y
Harefuah; 1997 Nov; 133(9):365-6, 414. PubMed ID: 9418339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
